# Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

> **NCT00812188** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Symmetric Limited Morphea

## Interventions

- **OTHER:** Medium Dose UVA-1
- **OTHER:** High Dose UVA-1

## Key facts

- **NCT ID:** NCT00812188
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812188, "Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00812188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*